Skip to main content

Table 2 Hazard Ratio (95% CI) for risks of CVD events, CHD, Stroke, CVD death at pre-defined levels of HbA1c

From: Associations between glycated hemoglobin and the risks of incident cardiovascular diseases in patients with gout

Outcome

No. of events/no. of patients

HbA1c (%)

4.5

5.0

5.5

6.0

6.5

7.0

7.5

8.0

Primary outcome

 CVD events

1095/6685

0.78 (0.56–1.09)

0.65 (0.53–0.81)

0.68 (0.57–0.81)

0.85 (0.78–0.92)

0.95 (0.91–0.99)

Ref.

1.05 (1.00–1.10)

1.09 (1.00–1.21)

Secondary outcomes

 CHD

916/6685

0.75 (0.52–1.10)

0.70 (0.55–0.89)

0.75 (0.62–0.91)

0.89 (0.81–0.98)

0.97 (0.92–1.02)

Ref.

1.03 (0.97–1.09)

1.05 (0.94–1.18)

 Stroke

151/6685

1.00 (0.50–2.01)

0.53 (0.31–0.91)

0.46 (0.30–0.70)

0.64 (0.54–0.77)

0.82 (0.75–0.90)

Ref.

1.20 (1.09–1.32)

1.44 (1.19–1.76)

 CVD death

144/6685

0.58 (0.22–1.53)

0.48 (0.26–0.87)

0.53 (0.33–0.85)

0.74 (0.61–0.90)

0.89 (0.81–0.99)

Ref.

1.10 (0.99–1.24)

1.22 (0.97–1.53)

  1. CI confidence interval, CVD cardiovascular disease, CHD coronary heart disease, HbA1c hemoglobin A1c, Ref reference